| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |